Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthequity (HQY) Short term Debt (2019 - 2023)

Healthequity has reported Short term Debt over the past 5 years, most recently at $17.5 million for Q1 2023.

  • Quarterly results put Short term Debt at $17.5 million for Q1 2023, up 100.0% from a year ago — trailing twelve months through Jan 2023 was $17.5 million (up 100.0% YoY), and the annual figure for FY2023 was $17.5 million, up 100.0%.
  • Short term Debt for Q1 2023 was $17.5 million at Healthequity, up from $15.3 million in the prior quarter.
  • Over the last five years, Short term Debt for HQY hit a ceiling of $78.1 million in Q3 2021 and a floor of $6.6 million in Q4 2021.
  • Median Short term Debt over the past 5 years was $35.2 million (2019), compared with a mean of $36.4 million.
  • Biggest five-year swings in Short term Debt: tumbled 89.5% in 2021 and later skyrocketed 133.32% in 2022.
  • Healthequity's Short term Debt stood at $31.2 million in 2019, then skyrocketed by 100.0% to $62.5 million in 2020, then tumbled by 89.5% to $6.6 million in 2021, then skyrocketed by 133.32% to $15.3 million in 2022, then increased by 14.28% to $17.5 million in 2023.
  • The last three reported values for Short term Debt were $17.5 million (Q1 2023), $15.3 million (Q4 2022), and $13.1 million (Q3 2022) per Business Quant data.